药品注册申请号:050006
申请类型:NDA (新药申请)
申请人:PFIZER
申请人全名:PFIZER LABORATORIES DIV PFIZER INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 VIBRAMYCIN DOXYCYCLINE FOR SUSPENSION;ORAL EQ 25MG BASE/5ML Yes Yes AB 1967/12/06 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2019/12/20 SUPPL-92(补充) Approval Labeling STANDARD
2018/12/03 SUPPL-91(补充) Approval Labeling STANDARD
2017/07/26 SUPPL-89(补充) Approval Labeling STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
2016/12/21 SUPPL-88(补充) Approval Labeling STANDARD
2016/03/31 SUPPL-87(补充) Approval Labeling STANDARD
2014/09/12 SUPPL-86(补充) Approval Labeling STANDARD
2013/09/04 SUPPL-85(补充) Approval Labeling STANDARD
2013/04/29 SUPPL-84(补充) Approval Labeling STANDARD
2011/05/11 SUPPL-82(补充) Approval Labeling STANDARD
2008/02/06 SUPPL-79(补充) Approval Labeling STANDARD
2004/03/12 SUPPL-76(补充) Approval Labeling STANDARD
2002/06/18 SUPPL-74(补充) Approval Labeling STANDARD
1992/12/15 SUPPL-73(补充) Approval Efficacy
1992/05/11 SUPPL-7(补充) Approval Labeling
1992/05/11 SUPPL-5(补充) Approval Labeling
1991/08/23 SUPPL-4(补充) Approval Labeling
1983/11/21 SUPPL-2(补充) Approval Labeling
1983/03/29 SUPPL-1(补充) Approval Labeling
1982/08/31 SUPPL-72(补充) Approval Labeling
1981/10/20 SUPPL-70(补充) Approval Manufacturing (CMC)
1981/10/19 SUPPL-71(补充) Approval Manufacturing (CMC)
1980/09/17 SUPPL-69(补充) Approval Manufacturing (CMC)
1980/09/16 SUPPL-68(补充) Approval Manufacturing (CMC)
1980/08/12 SUPPL-67(补充) Approval Labeling
1979/09/20 SUPPL-65(补充) Approval Manufacturing (CMC)
1979/09/19 SUPPL-66(补充) Approval Manufacturing (CMC)
1978/10/19 SUPPL-64(补充) Approval Manufacturing (CMC)
1978/07/12 SUPPL-63(补充) Approval Labeling
1978/07/12 SUPPL-62(补充) Approval Labeling
1978/03/13 SUPPL-61(补充) Approval Labeling
1977/09/21 SUPPL-59(补充) Approval Manufacturing (CMC)
1977/09/20 SUPPL-60(补充) Approval Labeling
1977/09/14 SUPPL-58(补充) Approval Manufacturing (CMC)
1976/12/06 SUPPL-57(补充) Approval Manufacturing (CMC)
1976/09/13 SUPPL-56(补充) Approval Manufacturing (CMC)
1976/09/10 SUPPL-55(补充) Approval Manufacturing (CMC)
1976/05/20 SUPPL-54(补充) Approval Manufacturing (CMC)
1976/04/09 SUPPL-53(补充) Approval Manufacturing (CMC)
1976/01/15 SUPPL-52(补充) Approval Labeling
1975/12/01 SUPPL-51(补充) Approval Manufacturing (CMC)
1975/09/16 SUPPL-48(补充) Approval Manufacturing (CMC)
1975/09/03 SUPPL-50(补充) Approval Manufacturing (CMC)
1975/09/03 SUPPL-49(补充) Approval Manufacturing (CMC)
1975/04/18 SUPPL-47(补充) Approval Labeling
1974/09/24 SUPPL-46(补充) Approval Manufacturing (CMC)
1974/09/24 SUPPL-45(补充) Approval Manufacturing (CMC)
1974/06/21 SUPPL-44(补充) Approval Manufacturing (CMC)
1974/06/06 SUPPL-43(补充) Approval Labeling
1974/04/16 SUPPL-42(补充) Approval Labeling
1973/10/30 SUPPL-39(补充) Approval Labeling
1973/10/30 SUPPL-38(补充) Approval Labeling
1973/10/30 SUPPL-37(补充) Approval Labeling
1973/10/30 SUPPL-36(补充) Approval Labeling
1973/10/02 SUPPL-41(补充) Approval Manufacturing (CMC)
1973/10/02 SUPPL-40(补充) Approval Manufacturing (CMC)
1973/07/02 SUPPL-35(补充) Approval Labeling
1973/03/16 SUPPL-34(补充) Approval Labeling
1972/09/18 SUPPL-33(补充) Approval Manufacturing (CMC)
1972/06/23 SUPPL-32(补充) Approval Labeling
1972/06/09 SUPPL-31(补充) Approval Labeling
1971/09/16 SUPPL-30(补充) Approval Manufacturing (CMC)
1971/05/25 SUPPL-29(补充) Approval Labeling
1971/03/12 SUPPL-28(补充) Approval Labeling
1971/02/22 SUPPL-27(补充) Approval Manufacturing (CMC)
1971/02/08 SUPPL-26(补充) Approval Labeling
1970/10/14 SUPPL-24(补充) Approval Manufacturing (CMC)
1970/10/09 SUPPL-25(补充) Approval Manufacturing (CMC)
1970/04/01 SUPPL-23(补充) Approval Manufacturing (CMC)
1970/03/12 SUPPL-22(补充) Approval Manufacturing (CMC)
1970/03/12 SUPPL-21(补充) Approval Manufacturing (CMC)
1969/11/19 SUPPL-20(补充) Approval Labeling
1969/11/07 SUPPL-19(补充) Approval Manufacturing (CMC)
1969/09/09 SUPPL-17(补充) Approval Manufacturing (CMC)
1969/09/08 SUPPL-18(补充) Approval Manufacturing (CMC)
1969/07/31 SUPPL-16(补充) Approval Labeling
1969/06/12 SUPPL-15(补充) Approval Manufacturing (CMC)
1969/02/11 SUPPL-14(补充) Approval Manufacturing (CMC)
1969/02/11 SUPPL-13(补充) Approval Labeling
1968/12/30 SUPPL-12(补充) Approval Labeling
1968/12/18 SUPPL-11(补充) Approval Manufacturing (CMC)
1968/06/19 SUPPL-9(补充) Approval Manufacturing (CMC)
1968/06/13 SUPPL-10(补充) Approval Labeling
1968/04/08 SUPPL-8(补充) Approval Manufacturing (CMC)
1968/02/05 SUPPL-6(补充) Approval Manufacturing (CMC)
1967/12/06 ORIG-1(原始申请) Approval UNKNOWN
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:DOXYCYCLINE 剂型/给药途径:FOR SUSPENSION;ORAL 规格:EQ 25MG BASE/5ML 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
050006 001 NDA VIBRAMYCIN DOXYCYCLINE FOR SUSPENSION;ORAL EQ 25MG BASE/5ML Prescription Yes Yes AB Approved Prior to Jan 1, 1982 PFIZER
065454 001 ANDA DOXYCYCLINE DOXYCYCLINE FOR SUSPENSION;ORAL EQ 25MG BASE/5ML Prescription No No AB 2008/07/16 CHARTWELL
201678 001 ANDA DOXYCYCLINE DOXYCYCLINE FOR SUSPENSION;ORAL EQ 25MG BASE/5ML Prescription No No AB 2013/03/18 LUPIN LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database